A new anti-hemoglobin F antibody against synthetic peptides for the detection of F-cell precursors (F-blasts) in bone marrow
- PMID: 11721963
- DOI: 10.1007/BF02982061
A new anti-hemoglobin F antibody against synthetic peptides for the detection of F-cell precursors (F-blasts) in bone marrow
Abstract
To date there are few antibodies available for the detection of fetal hemoglobin (HbF)-containing erythroblasts (F-blasts) in paraffin-embedded hematopoietic tissues. Recently, we developed a new polyclonal antibody specific to F-blasts by immunization of a rabbit with synthetic peptides of human HbF. Specificity and reactivity of the antibody were confirmed by enzyme-linked immunosorbent assay (ELISA) and immunohistochemistry. ELISA confirmed that the antibody showed strong immunoreactivity to fetal hemoglobin but no reaction to adult hemoglobin. The antibody could detect the presence of fetal blood hemolysates (10 microg/mL) at a dilution of 10(-5). According to immunohistochemical analysis, there were strong positive reactions to fetal erythroblasts in the liver and the spleen at 29 weeks of gestation and to erythroblasts from patients with myelodysplastic syndromes and erythroleukemia but no reactions to normal adult erythroblasts in bone marrow. Fetal erythrocytes in fetal blood vessels of placental tissues were strictly distinguished from maternal erythrocytes in the same sections by their positive reactions, indicating the presence of HbF. This new antibody will be a useful tool for studying fetal hemoglobin synthesis and for detecting F-blasts in archival specimens of various hematological diseases.
Similar articles
-
Significance of fetal hemoglobin-containing erythroblasts (F blasts) and the F blast/F cell ratio in myelodysplastic syndromes.Leukemia. 2002 Aug;16(8):1478-83. doi: 10.1038/sj.leu.2402536. Leukemia. 2002. PMID: 12145688
-
[Use of specific antibody to detect fetal erythroblasts in maternal circulation].Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2004 Oct;21(5):494-7. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2004. PMID: 15476180 Chinese.
-
Erythroleukemia shares biological features and outcome with myelodysplastic syndromes with excess blasts: a rationale for its inclusion into future classifications of myelodysplastic syndromes.Mod Pathol. 2016 Dec;29(12):1541-1551. doi: 10.1038/modpathol.2016.146. Epub 2016 Aug 26. Mod Pathol. 2016. PMID: 27562492
-
Acute erythroid neoplastic proliferations. A biological study based on 62 patients.Haematologica. 2002 Feb;87(2):148-53. Haematologica. 2002. PMID: 11836165 Review.
-
[The role of bone marrow cells immunophenotypic study by flow cytometry in diagnosing myelodysplastic syndrome].Postepy Hig Med Dosw (Online). 2008 Jul 23;62:354-63. Postepy Hig Med Dosw (Online). 2008. PMID: 18688206 Review. Polish.
Cited by
-
Developmental and species-divergent globin switching are driven by BCL11A.Nature. 2009 Aug 27;460(7259):1093-7. doi: 10.1038/nature08243. Epub 2009 Aug 5. Nature. 2009. PMID: 19657335 Free PMC article.
-
The diagnosis from the pathological viewpoint of a blood disease.Int J Hematol. 2002 Aug;76 Suppl 2:2-5. doi: 10.1007/BF03165076. Int J Hematol. 2002. PMID: 12430891 Review.
-
F-blast is a useful marker for differentiating hypocellular refractory anemia from aplastic anemia.Int J Hematol. 2002 Apr;75(3):257-60. doi: 10.1007/BF02982038. Int J Hematol. 2002. PMID: 11999352
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources